Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Native wharton's jelly stem cells and their purification

a technology of stem cells and whartons, applied in the field of native whartons jelly stem cells and their purification, can solve the problems of undigested tissue fragments left behind by incomplete digestion

Inactive Publication Date: 2013-05-16
TAGHIZADEH ROUZBEH R
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent text describes a method for separating digested and undigested tissue, such as by sedimenting or filtering the undigested tissue. The technique can be accelerated by centrifugation and can even be effective without a washing or diluting step. The technical effect of this method is to provide a reliable and efficient way to separate and collect noncultured Wharton's Jelly stem cells from tissue samples.

Problems solved by technology

Incomplete digestion can leave fragments of undigested tissue.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Native wharton's jelly stem cells and their purification
  • Native wharton's jelly stem cells and their purification
  • Native wharton's jelly stem cells and their purification

Examples

Experimental program
Comparison scheme
Effect test

example 1

Purification of Native Wharton's Jelly Stem Cells and Homogeneous Wharton's Jelly Solution

[0026]Umbilical cords were collected in sterile specimen containers within 48 hours of the time of delivery. In a bio safety cabinet, 10 mL of Buffer B (50 μg / mL gentamicin, 100 units / mL penicillin and 100 μg / mL streptomycin in sterile Dulbecco's phosphate buffered saline) were added to the umbilical cord in an umbilical cord collection chamber. Other antibiotics, such as 0.25 μg / mL amphotericin B, 100 μg / mL streptomycin and / or 10 μg / mL ciprofloxacin, can also be added to Buffer B or substituted for any of the antibiotics in Buffer B. The contents of the collection chamber were then mixed by swirling and maintained at room temperature for fewer than 72 hours. The contents were swirled again for approximately 10-15 seconds to clean the umbilical cord tissue. Coagulated blood, if evident on the surface of the umbilical cord, was carefully removed using dissection tools.

[0027]The umbilical cord wa...

example 2

Storage of Noncultured Wharton's Jelly Stem Cells

[0039]The purified cell suspension of Example 1 was cryopreserved in a 25 mL freezing bag. Using a 60 mL syringe with an 18 G needle, 16 mL of autologous plasma, 5% human serum albumin, or a combination thereof were added to the 4 mL purified Wharton's Jelly stem cell suspension. An alcohol pad was used to wipe the top of a vial of 55% DMSO / 5% Dextran. Next, 5 mL of the DMSO / Dextran mixture were removed using a 60 mL syringe with an 18 G needle and slowly added to the cell suspension. The cell suspension tube was capped tightly and gently inverted to mix, taking care not to make foam or bubbles. Using the same 60 mL syringe, 25 mL of the cell suspension were transferred to the freezing bag. The freezing bag was stored in a metal canister in a Styrofoam holder at −80° C. for 16 to 24 hours, optionally followed by an intervening period in a liquid nitrogen freezer in which the cells were exposed only to the vapor phase of the liquid nit...

example 3

In vivo Efficacy

[0040]The therapeutic efficacy of noncultured Wharton's Jelly stem cells was demonstrated in a co-transplantation assay with hematopoietic stem cells from umbilical cord blood to renew a mammalian hematopoietic system.

[0041]Hematopoietic stem cells from umbilical cord blood can be administered to a mammal to reconstitute a hematopoietic system damaged, for example, by radiation. Co-transplantation of Wharton's Jelly stem cells improves the reconstitution process, enhancing the engraftment of the administered hematopoietic stem cells and, therefore, their ability to proliferate and recreate a hematopoietic system in their new host.

[0042]To test the efficacy of noncultured Wharton's Jelly stem cells, they were co-administered with hematopoietic stem cells from umbilical cord blood to (NOD / SCID IL2Rγ-null) mice that had been sublethally irradiated the day before with 300 cGy of gamma-radiation which ablated the bone marrow. 1,000,000 mononuclear umbilical cord blood cel...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Noncultured Wharton's Jelly stem cells and methods of their purification, storage and use are provided.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application claims the benefit of and priority to U.S. Provisional Application No. 61 / 350,303, filed Jun. 1, 2010, the disclosure of which is hereby incorporated by reference in its entirety.BACKGROUND OF THE INVENTION[0002]Umbilical cord tissue is a rich source of stem cells. Blood from the umbilical cord includes stem cells, including hematopoietic stem cells that can be used to repopulate a person's blood and immune system. Wharton's Jelly, a gelatinous substance within the umbilical cord, contains an additional population of stem cells, distinct from those found in cord blood. As used herein, “Wharton's Jelly” can further include the amniotic epithelial layer of the umbilical cord. Processing and culturing the Wharton's Jelly permits the isolation of mesenchymal stem cells that can be used to regenerate a variety of tissues (see, for example, U.S. Pat. No. 5,919,702).SUMMARY OF THE INVENTION[0003]The present inventors have discov...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/073
CPCC12N5/0605A61L27/3834A61K35/51C12N5/00C12N5/06C12N2500/84C12N5/0662C12N2502/025C12N5/0037C12N5/0602C12N5/0668
Inventor TAGHIZADEH, ROUZBEH R.
Owner TAGHIZADEH ROUZBEH R
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com